Student Training

Medical Student Elective Clerkship

Medical Students from US and selected foreign medical schools are eligible to participate in an elective in Internal Medicine or Pediatric Endocrinology. The experience is much as described under the link to “ROTATION AND ELECTIVE”. If you are interested in applying for a student elective, please go to the Handbook for 4th Year Medical Students.

Other Training Opportunities

TL1 Program https://ctsi.ucla.edu/education-and-training/pre-doctoral-and-post-doctoral-programs-tl1-program/about

  • The TL1 leverages UCLA, CDU, Cedars-Sinai, and Harbor-Lundquist faculty to provide curriculum and mentorship that enable each trainee to acquire translational competencies and become well-versed in the application of relevant methods.

The program:

  • Delivers a curriculum that builds core competencies in T3/T4 translational methods focused on population health;
  • Delivers a curriculum that builds core competencies in T3/T4 translational methods focused on population health;
  • Delivers a curriculum that builds core competencies in T3/T4 translational methods focused on population health;

KL2 Program https://ctsi.ucla.edu/education-and-training/junior-faculty-programs

    • The program is designed to provide the next generation of clinicians and researchers with the training they need to conduct research to improve health.
    • The Program goals are to:
      • improve the success of junior faculty pursuing translational science careers;
      • enhance their ability to make important scientific discoveries that will lead to better health;
      • translate those scientific discoveries to patients and communities ;
      • increase diversity of the scientific workforce.

Masters Programs and Certificate Programs Delivered by the Training Program in Translational Science (TPTS) https://ctsi.ucla.edu/education-and-training/masters-programs-and-certificate-programs

  • The CTSI Training Program in Translational Science (TPTS) formerly known as the UCLA K30 Program) was developed to provide clinicians with the necessary training to become successful patient-oriented investigators who can bridge molecular medicine and clinical research. Participants have a high commitment to clinical research and must have either professional health degrees (e.g., medicine, nursing, dentistry) or a doctorate. In addition, participants must be affiliated with UCLA, Lundquist/Harbor-UCLA, Cedars-Sinai, or Charles R. Drew University of Medicine and Science (the CTSI partner institutions).

NIH Grant Writing Bootcamp (Spring 2024)

  • The UCLA Clinical and Translational Science Institute (CTSI) and DGSOM Office of Physician Scientist Career Development is offering a NIH Grant Writing Bootcamp for junior faculty and trainees who are submitting their first NIH K or R application.

Investigator Courses/Workshops at The Lundquist Institute:

    • Spring/Fall Biostatistics Short Course
    • Offered twice a year by Youngju Pak, PhD

This course is designed to learn fundamental statistical theories and their applications in preclinical and clinical trials.  These are hybrid sessions, and everyone is welcome to join.

Grant Writing Workshop

  • Offered bimonthly by Scott Filler, MD and Michael Yeaman, PhD

Dr. Michael Yeaman and Dr. Scott Filler are experienced and successful grant writers. They will be conducting interactive workshops to share their thoughts and insights on this process.

Interactive Research Design

  • Offered Once a year by Roger Lewis, MD

In person, interactive discussions for all investigators.  Bring your ideas, and Roger Lewis will discuss your project or an idea for a possible project and help you develop and refine your research design, outcome measure and statistical analysis plan.

WINN CIPP Program (Robert A. Winn Diversity in Clinical Trials: Clinical Investigator Pathway Program)

    • Offered once a year by Lundquist Mentors

The goal of the WINN CIPP program is to build a pathway of community-oriented clinical trialists of diverse backgrounds who are committed to increasing inclusion, equity, and diversity in the conduct of clinical and translational research.